Maurice Evans
About Maurice Evans
Maurice E. (Mo) Evans, age 44, has served as an independent director of IMAC Holdings (ticker BACK) since his appointment on October 31, 2020. He is principal and co-founder of ELOS Sports and Entertainment LLC, and previously played 11 seasons in the NBA and served as Executive Vice President of the NBA Players Association (2010–2013). He holds a B.A. from the University of Texas at Austin and brings customer-centric leadership experience relevant to IMAC’s patient-facing businesses .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| NBA Players Association | Executive Vice President | 2010–2013 | Senior leadership during 2011 CBA negotiations |
| NBA (multiple teams) | Professional Basketball Player | 2001–2012 | 562 NBA games; community/sponsor outreach experience |
| ELOS Sports & Entertainment, LLC | Principal/Co-founder | 2014–present | Brand management for athletes and corporations |
External Roles
| Organization | Role | Public/Private | Notes |
|---|---|---|---|
| ELOS Sports & Entertainment, LLC | Principal | Private | Branding/management services; Evans is principal |
| The MOLO Agency | Owner | Private | Provided marketing services to IMAC in 2022; $27,000 paid; $0 in 2023 (related-party) |
Board Governance
- Independence: The Board determined Evans is independent under Nasdaq rules; independence reaffirmed in filings despite related-party MOLO Agency services .
- Committee assignments: Audit Committee member; Compensation Committee Chair; Nominating & Governance Committee member (consistent across 2021–2024 proxies). Audit Chair is Michael Pruitt; N&G Chair is Cary Sucoff .
- Committee activity: In 2023, Audit Committee met 4 times; Compensation Committee met 1 time .
- Director election/tenure: First appointed October 31, 2020; nominee listings show continued service; age 44 in 2024 proxy .
- Annual meeting attendance: All directors then serving attended the 2023 annual meeting .
Fixed Compensation
| Metric | FY 2020 | FY 2021 | FY 2022 | FY 2023 |
|---|---|---|---|---|
| Cash Fees ($) | $2,000 | $38,833 | $45,000 | $45,000 |
Notes:
- 2023 description indicates $11,250 per quarter cash paid to each non-employee director .
Performance Compensation
| Equity Component | FY 2020 | FY 2021 | FY 2022 | FY 2023 |
|---|---|---|---|---|
| Stock Awards (Fair Value $) | $80,000 RSUs | $0 | $100,000 RSUs | $14,300 RSUs |
| Grant Details | RSUs for 100,000 shares covering 2 years; vest in 8 equal quarterly installments | — | Annual RSU grant (fair value at grant per ASC 718) | 3,333 RSUs granted with immediate vesting during FY 2023 |
| Options | None disclosed | None disclosed | None disclosed | None disclosed |
| Performance Metrics | None disclosed; director equity awards not tied to financial/ESG metrics | — | — | — |
Other Directorships & Interlocks
| Company | Role | Notes |
|---|---|---|
| None disclosed | — | No other public company directorships for Evans disclosed in company filings . |
Expertise & Qualifications
- Customer-centric leadership via NBA Players Association and ELOS; relevant to patient experience and brand positioning .
- Board service tenure since 2020; continuity valued by the company .
Equity Ownership
| As-of Date | Shares Beneficially Owned | % of Shares Outstanding | Composition/Notes |
|---|---|---|---|
| June 18, 2021 (Record Date, FY 2021 proxy context) | Not specified in table excerpt | — | Security ownership table presented for 2021; Evans listed as Audit Committee member; detailed amounts not in shown excerpt . |
| Record Date 2021 (FY 2022 proxy) | 242,122 | <1% | Includes 129,702 shares held by ELOS; Evans as principal has sole voting/investment power . |
| January 27, 2025 (Special Meeting Record Date) | 18,071 | <1% | Current beneficial ownership per special proxy; reflects reverse split and capital structure changes . |
Policies and alignment:
- Related party policy in place; Audit Committee reviews independence impacts of related transactions (e.g., MOLO Agency) .
- No disclosures of hedging or pledging by Evans found in reviewed filings; stock ownership guidelines for directors not disclosed in proxies reviewed .
Governance Assessment
-
Strengths:
- Independent director serving as Compensation Committee Chair; consistent committee roles across years (signals governance continuity) .
- Active Audit Committee member; audit committee met 4x in 2023 (engagement with financial reporting oversight) .
- Attendance at annual meeting by all directors in 2023 supports engagement .
-
Potential concerns/RED FLAGS:
- Related-party transactions: MOLO Agency owned by Evans provided services ($27,000 in 2022; $0 in 2023). While independence was reaffirmed, any recurrence or increase would require careful monitoring and robust committee oversight .
- Compensation volatility and equity structure: Shift from larger RSU fair values in 2022 ($100k) to smaller, immediately-vested RSUs in 2023 ($14.3k) reduces at-risk alignment; immediate vesting lowers retention/performance linkage for director equity .
- Dilutive capital actions: Company’s 2025 special proxy outlines significant potential dilution through preferred/warrant conversions and committed equity financing; while not specific to Evans, board oversight of shareholder dilution is a governance sensitivity for investor confidence .
-
Overall: Evans’ independence and leadership on compensation governance are positives. The minor related-party engagement appears monitored and immaterial in 2023, but warrants continued scrutiny. Director equity grants lack performance metrics; investors may prefer stronger ownership alignment mechanisms for board members .